Personal information

Emails & domains

Verified email domains

Other IDs

SciProfiles: 2139217

Activities

Collapse all

Works (13)

CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib

Blood Neoplasia
2024-06 | Journal article
DOI: 10.1016/j.bneo.2024.100014
Contributors: Chung Hoow Kok; Yazad Irani; Jade Clarson; Verity Saunders; Phuong Dang; Naranie Shanmuganathan; Susan Branford; David Yeung; Agnes S. M. Yong; Timothy P. Hughes
Source: check_circle
Crossref

Special Issue “Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms”

International Journal of Molecular Sciences
2024-02-08 | Journal article
DOI: 10.3390/ijms25042056
Contributors: Chung Hoow Kok; David T. Yeung; Devendra K. Hiwase
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha

British Journal of Haematology
2023-09 | Journal article
DOI: 10.1111/bjh.18984
Contributors: Yazad D. Irani; Amy Hughes; Chung H. Kok; Jade Clarson; David T. Yeung; David M. Ross; Susan Branford; Timothy P. Hughes; Agnes S. M. Yong
Source: check_circle
Crossref

Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib

Blood Cancer Journal
2023-09-11 | Journal article
DOI: 10.1038/s41408-023-00917-4
Contributors: Chung H. Kok; Verity A. Saunders; Phuong Dang; Naranie Shanmuganathan; Deborah White; Susan Branford; David Yeung; Timothy P. Hughes
Source: check_circle
Crossref

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data

Cancers
2023-08 | Journal article | Author
DOI: 10.3390/cancers15164019
Contributors: Kirsty Sharplin; William Proudman; Rakchha Chhetri; Elizabeth Ngoc Hoa Tran; Jamie Choong; Monika Kutyna; Philip Selby; Aidan Sapio; Oisin Friel; Shreyas Khanna et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines

International Journal of Molecular Sciences
2023-02-10 | Journal article
DOI: 10.3390/ijms24043553
Contributors: Monika M. Kutyna; Sophie Loone; Verity A. Saunders; Deborah L. White; Chung H. Kok; Devendra K. Hiwase
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure

Leukemia
2022-11 | Journal article
DOI: 10.1038/s41375-022-01686-y
Contributors: Monika M. Kutyna; Chung Hoow Kok; Yoon Lim; Elizabeth Ngoc Hoa Tran; David Campbell; Sharon Paton; Chloe Thompson-Peach; Kelly Lim; Dimitrios Cakouros; Agnes Arthur et al.
Source: check_circle
Crossref

Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment‐free remission

British Journal of Haematology
2022-08 | Journal article
DOI: 10.1111/bjh.18277
Contributors: Liu Lu; Chung Hoow Kok; Phuong Dang; Susan Branford; Verity A. Saunders; Naranie Shanmuganathan; David M. Ross; Timothy P. Hughes; David T. O. Yeung
Source: check_circle
Crossref

Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms

American Journal of Hematology
2022-08 | Journal article
DOI: 10.1002/ajh.26589
Contributors: Mithun Vinod Shah; Rakchha Chhetri; Ruchita Dholakia; Chung H. Kok; Naseema Gangat; Hassan B. Alkhateeb; Aref Al‐Kali; Mrinal M. Patnaik; Anmol Baranwal; Patricia T. Greipp et al.
Source: check_circle
Crossref

CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre‐B‐cell acute lymphoblastic leukaemia

British Journal of Haematology
2021-04 | Journal article
DOI: 10.1111/bjh.17161
Contributors: Stephen Fitter; Alanah L. Bradey; Chung Hoow Kok; Jacqueline E. Noll; Vicki J. Wilczek; Nicola C. Venn; Tamara Law; Sakrapee Paisitkriangkrai; Colin Story; Lynda Saunders et al.
Source: check_circle
Crossref

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

British Journal of Haematology
2020-11 | Journal article
DOI: 10.1111/bjh.16718
Contributors: Yazad D. Irani; Amy Hughes; Jade Clarson; Chung H. Kok; Naranie Shanmuganathan; Deborah L. White; David T. Yeung; David M. Ross; Timothy P. Hughes; Agnes S.M. Yong
Source: check_circle
Crossref

Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib

Blood Advances
2019-05-28 | Journal article
DOI: 10.1182/bloodadvances.2019000195
Contributors: Chung H. Kok; David T. Yeung; Liu Lu; Dale B. Watkins; Tamara M. Leclercq; Phuong Dang; Verity A. Saunders; John Reynolds; Deborah L. White; Timothy P. Hughes
Source: check_circle
Crossref

Co-fuse: a new class discovery analysis tool to identify and prioritize recurrent fusion genes from RNA-sequencing data

Molecular Genetics and Genomics
2018-10 | Journal article
DOI: 10.1007/s00438-018-1454-1
Part of ISSN: 1617-4615
Part of ISSN: 1617-4623
Source: Self-asserted source
Chung Hoow Kok

Peer review (4 reviews for 1 publication/grant)

Review activity for Leukemia research. (4)
How many people are using ORCID?